Induction of lipoprotein lipase gene expression in Chlamydia pneumoniae-infected macrophages is dependent on Ca2+ signaling events

Biological Chemistry

Volumn 385, Issue 1, 2004, Pages 67-74

  Azenabor, Anthony A ^a   Job, Godwin ^a   Yang, Shoua ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

C. pneumoniae; Ca2+ signaling; LDL uptake; Lipoprotein lipase

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CALPHOSTIN C; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FOAM CELL; GENE EXPRESSION; GENE INDUCTION; MACROPHAGE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; UPREGULATION;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CHLAMYDOPHILA PNEUMONIAE; EGTAZIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MACROPHAGES; MICE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 1242343960     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.009     Document Type: Article

References (42)

1. 2+ influx and down regulates interleukin-2 receptor in mouse thymocytes. Biochem. Biophys. Res. Commun. 281, 277-281.
2. 2+ dependent reactive nitrogen and oxygen species. J. Infect. 46, 120-128.
3. 2+ channel activation. Med. Microbiol. Immunol. 192, 99-106.
4. Beauchamp, M.C., and Renier, G. (2002). Homocysteine induces protein kinase C activation and stimulates c-Fos and lipo-protein lipase expression in macrophages. Diabetes 51, 1180-1187.
5. Blessing, E., Lin, T.M., Campbell, L.A., Rosenfeld, M.E., Lloyd, D., and Kuo, C.C. (2000). Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normo-cholesterolemic C57BL/6J mice. Infect. Immun. 68, 4765-4768.
6. Brade, H. (1999). In: Endotoxin in Health and Disease, H. Brade, D.C., Morrison, S. Opaland and S. Vogel, eds. (New York, USA: Marcel Dekker, Inc.).
7. Brade, L., Schramek, S., Schade, U., and Brade, H. (1986). Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect. Immun. 54, 568-574.
8. Bustin, S.A. (2002). Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29, 23-39.
9. Campbell, L.A., O'Brien, E.R., Cappuccio, A.L., Kuo, C.C., Wang, S.P., Stewart, D., Patton, D.L., Cummings, P.K., and Grayston, J.T. (1995). Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172, 585-588.
10. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Fong, I.W. (2000). Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. J. Infect. Dis. 181, S514-518.
12. Fong, I.W., Chiu, B., Viira, E., Jang, D., and Mahony, J.B. (1999). De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect. Immun. 67, 6048-6055.
13. Goldstein, J.L., and Brown, M.S. (1987). Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 76, 504-507
14. Grayston, J.T., Kuo, C.C., Campbell, L.A., and Benditt, E.P. (1993). Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur. Heart J. 14, 66-71.
15. Hahn, D.L., Azenabor, A.A., Beatty, W.L., and Byrne, G.I. (2002). Chlamydia pneumoniae as a respiratory pathogen. Front. Biosci. 7, e66-e76.
16. Ingalls, R.R., Rice, P.A., Qureshi, N., Takayama, K., Lin, J.S., and Golenbock, D.T. (1995). The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63, 3125-3130.
17. Kuo, C.C., Grayston, J.T., Campbell, L.A., Goo, Y.A., Wissler, R.W., and Benditt, E.P. (1995). Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92, 6911-6914.
18. Kuo, C.C., and Campbell, L.A. (1998). Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol. Med. Today 4, 426-430.
19. Medh, J.D., Bowen, S.L., Fry, G.L., Ruben, S., Andracki, M., Inoue, I., Lalouel, J.M., Strickland, D.K., and Chappell, D.A. (1996). Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J. Biol. Chem. 271, 17073-17080.
20. Meier, C.R. (2000). Antibiotics in the prevention and treatment of coronary heart disease. J. Infect. Dis. 181, S558-562.
21. Melnick, J.L., Hu, C., Burek, J., Adam, E., and DeBakey, M.E. (1994). Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42, 170-174.
22. Moazed, T.C., Kuo, C.C., Grayston, J.T., and Campbell, L.A. (1997). Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175, 883-890.
23. Muhlestein, J.B., Hammond, E.H., Carlquist, J.F., Radicke, E., Thomson, M.J., Karagounis, L.A., Woods, M.L., and Anderson, J.L. (1996). Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Am. Coll. Cardiol. 27, 1555-1561.
24. Obunike, J.C., Edwards, I.J., Rumsey. S.C., Curtiss, L.K., Wagner, W.D., Deckelbaum, R.J., and Goldberg, I.J. (1994). Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J. Biol. Chem. 269, 13129-13135.
25. Raetz, C.R., and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700.
26. Ramirez, J.A. (1996). Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. Intern. Med. 125, 979-982.
27. Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Zahringer, U., Seydel, U., Di Padova, F. et al. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217-225.
28. Rosenfeld, M.E., Blessing, E., Lin, T.M., Moazed, T.C., Campbell, L.A., and Kuo, C.C. (2000). Chlamydia, inflammation, and atherogenesis. J. Infect. Dis. 181, S492-S497.
29. Ross, R. (1990). The pathogenesis of arteriosclerosis (a perspective for the 1990's). Nature 362, 801-809.
30. Rothstein, N.M., Quinn, T.C., Madico, G., Gaydos, C.A., and Lowenstein, C.J. (2001). Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J. Infect. Dis. 183, 232-238.
31. Rumsey, S.C., Obunike, J.C., Arad, Y., Deckelbaum, R.J., and Goldberg, I.J. (1992). Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 90, 1504-1512.
32. Saikku, P., Leinonen, M., Mattila, K., Ekman, M.R., Nieminen, M.S., Makela, P.H., Huttunen, J.K., and Valtonen, V. (1988). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983-986.
33. Shor, A., Kuo, C.C., and Patton, D.L. (1992). Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82, 158-161
34. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., and Klenk, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
35. Sorlie, P.D., Adam, E., Melnick, S.L., Folsom, A., Skelton, T., Chambless, L.E., Barnes, R., and Melnick, J.L. (1994). Cytomegalovirus/herpes virus and carotid atherosclerosis: the ARIC Study. J. Med. Virol. 42, 33-37.
36. Therond, P., Abella, A., Laurent, D., Couturier, M., Chalas, J., Legrand, A., and Lindenbaum A. (2000). In vitro study of the cytotoxicity of isolated oxidized lipid low-density lipoproteins fractions in human endothelial cells: relationship with the glutathione status and cell morphology. Free Radic. Biol. Med. 28, 584-596.
37. Thom, D.H., Grayston, J.T., Siscovick, D.S., Wang, S.P., Weiss, N.S., and Daling, J.R. (1992). Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268, 68-72.
38. Wang, X., Greilberger, J., Levak-Frank, S., Zimmermann, R., Zechner, R., and Jurgens, G. (1995). Endogenously produced lipoprotein lipase enhances the binding and cell association of native, mildly oxidized and moderately oxidized low-density lipoprotein in mouse peritoneal macrophages. Biochem. J. 343, 347-353.
39. Wang, X., Pease, R., Bertinato, J., and Milne, R.W. (2000). Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism. Arterioscler. Thromb. Vasc. Biol. 20, 1301-1308.
40. White, J.R., Chait, A., Klebanoff, S.J., Deeb, S., Brunzell, J.D. (1988). Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor. J. Lipid Res. 29, 1379-1385.
41. Yang, R.B., Mark, M.R., Gray, A., Huang, A., Xie, M.H., Zhuang, M., Goddard, A., Wood, W., Gurney, A., and Godowski, P.J. (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 398, 284-288.
42. Zhang, Y., Repa, J.J., Gauthier, K., and Mangelsdorf, D.J. (2001). Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J. Biol. Chem. 276, 43018-43024.